journal article·2023-07-01Open access

A microphysiological model of bone development and regeneration

Ian T Whelan, Ross Burdis, Somayeh Shahreza, Emad Moeendarbary, David A Hoey, Daniel J Kelly

Biofabrication· Volume 15· Issue 3

Abstract

Abstract Endochondral ossification (EO) is an essential biological process than underpins how human bones develop, grow, and heal in the event of a fracture. So much is unknown about this process, thus clinical manifestations of dysregulated EO cannot be adequately treated. This can be partially attributed to the absence of predictive in vitro models of musculoskeletal tissue development and healing, which are integral to the development and preclinical evaluation of novel therapeutics. Microphysiological systems, or organ-on-chip devices, are advanced in vitro models designed for improved biological relevance compared to traditional in vitro culture models. Here we develop a microphysiological model of vascular invasion into developing/regenerating bone, thereby mimicking the process of EO. This is achieved by integrating endothelial cells and organoids mimicking different stages of endochondral bone development within a microfluidic chip. This microphysiological model is able to recreate key events in EO, such as the changing angiogenic profile of a maturing cartilage analogue, and vascular induced expression of the pluripotent transcription factors SOX2 and OCT4 in the cartilage analogue. This system represents an advanced in vitro platform to further EO research, and may also serve as a modular unit to monitor drug responses on such processes as part of a multi-organ system.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Periodontal Regeneration and Treatments · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (61)

Show source-provided references
1. Cartilage to bone transformation during fracture healing is coordinated by the invading vasculature and induction of the core pluripotency genes10.1242/dev.130807 ↗
2. The multifaceted role of the vasculature in endochondral fracture repair10.3389/fendo.2015.00004 ↗
3. Fracture non-union epidemiology and treatment10.1177/1460408615591625 ↗
4. Martini · 2004
5. Juvenile osteochondritis dissecans of the knee is a result of failure of the blood supply to growth cartilage and osteochondrosis10.1016/j.joca.2018.06.019 ↗
6. Cartilage to bone transitions in health and disease10.1530/JOE-13-0276 ↗
7. Printing new bones: from print-and-implant devices to bioprinted bone organ precursors10.1016/j.molmed.2021.05.001 ↗
8. Limitations of autograft and allograft: new synthetic solutions10.3928/0147-7447-20020502-04 ↗
9. Tissue engineering whole bones through endochondral ossification: regenerating the distal phalanx10.1089/biores.2015.0014 ↗
10. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering10.1073/pnas.1000302107 ↗
11. 3D printed microchannel networks to direct vascularisation during endochondral bone repair10.1016/j.biomaterials.2018.01.057 ↗
12. 3D bioprinting of developmentally inspired templates for whole bone organ engineering10.1002/adhm.201600182 ↗
13. PTH/PTHrP receptor in early development and Indian hedgehog–regulated bone growth10.1126/science.273.5275.663 ↗
14. Osteoporotic fracture models10.1007/s11914-014-0246-8 ↗
15. Mechanisms of growth plate maturation and epiphyseal fusion10.1159/000327788 ↗
16. Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor10.1083/jcb.133.2.457 ↗
17. Chondrogenic ATDC5 cells: an optimised model for rapid and physiological matrix mineralisation10.3892/ijmm.2012.1114 ↗
18. Cellular hypertrophy and calcification of embryonal carcinoma‐derived chondrogenic cell line ATDC5 in vitro10.1359/jbmr.1997.12.8.1174 ↗
19. High density micromass cultures of embryonic limb bud mesenchymal cells: an in vitro model of endochondral skeletal development10.1007/s11626-999-0070-0 ↗
20. Apoptosis of terminal hypertrophic chondrocytes in an in vitro model of endochondral ossification10.1002/path.1462 ↗
21. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification10.1074/jbc.M602296200 ↗
22. Physiologically-based pharmacokinetic simulation modelling10.1016/S0169-409X(02)00013-3 ↗
23. Dual 3D printing for vascularized bone tissue regeneration10.1016/j.actbio.2021.01.012 ↗
24. Endothelial cells support osteogenesis in an in vitro vascularized bone model developed by 3D bioprinting10.1088/1758-5090/ab6a1d ↗
25. Biofabrication of prevascularised hypertrophic cartilage microtissues for bone tissue engineering10.3389/fbioe.2021.661989 ↗
26. Engineering of functional, perfusable 3D microvascular networks on a chip10.1039/c3lc41320a ↗
27. Advances in on-chip vascularization10.2217/rme-2016-0152 ↗
28. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation10.1073/pnas.1417115112 ↗
29. Hyperphysiological compression of articular cartilage induces an osteoarthritic phenotype in a cartilage-on-a-chip model10.1038/s41551-019-0406-3 ↗
30. On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology10.1038/s41551-019-0495-z ↗
31. Spatial patterning of phenotypically distinct microtissues to engineer osteochondral grafts for biological joint resurfacing10.1016/j.biomaterials.2022.121750 ↗
32. Fiji: an open-source platform for biological-image analysis10.1038/nmeth.2019 ↗
33. 3D reconstruction of histological sections: application to mammary gland tissue10.1002/jemt.20829 ↗
34. Hypoxia and mesenchymal stromal cells as key drivers of initial fracture healing in an equine in vitro fracture hematoma model10.1371/journal.pone.0214276 ↗
35. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation10.1038/9467 ↗
36. Cartilage to bone—angiogenesis leads the way10.1038/9460 ↗
37. Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis10.1016/j.joca.2013.08.018 ↗
38. Animal modeling in bone research—should we follow the white rabbit?10.1002/ame2.12083 ↗
39. The induction of bone formation: the translation enigma10.3389/fbioe.2018.00074 ↗
40. In vitrochondrogenesis of bone marrow-derived mesenchymal progenitor cells10.1006/excr.1997.3858 ↗
41. Oxygen tension regulates the osteogenic, chondrogenic and endochondral phenotype of bone marrow derived mesenchymal stem cells10.1016/j.bbrc.2011.11.105 ↗
42. Engineering high-quality cartilage microtissues using hydrocortisone functionalised microwells10.1089/ten.TEA.2021.0176 ↗
43. Integrated role of human thymic stromal cells in hematopoietic stem cell extravasation10.1002/btm2.10454 ↗
44. The tumour microenvironment modulates cancer cell intravasation10.1016/j.ooc.2022.100024 ↗
45. A robust method for perfusable microvascular network formation in vitro10.1002/smtd.202200143 ↗
46. Antiangiogenic and anticancer molecules in cartilage10.1017/erm.2012.3 ↗
47. Thrombospondins function as regulators of angiogenesis10.1007/s12079-009-0060-8 ↗
48. Endostatin/collagen XVIII—an inhibitor of angiogenesis—is expressed in cartilage and fibrocartilage10.1016/j.matbio.2004.06.003 ↗
49. Osteonectin/SPARC is a product of articular chondrocytes/cartilage and is regulated by cytokines and growth factors10.1016/0167-4889(94)90209-7 ↗
50. Modulation of endothelial cell survival by an inhibitor of angiogenesis thrombospondin-1: a dynamic balance10.1023/A:1026560618302 ↗
51. Novel antiangiogenic pathway of thrombospondin‐1 mediated by suppression of the cell cycle10.1111/j.1349-7006.2007.00534.x ↗
52. Thrombospondin‐1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor‐related protein‐1 (LRP‐1)10.1002/jcp.20904 ↗
53. A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first‐line therapy for patients with breast cancer (CBCRT 01)10.1002/ijc.31217 ↗
54. The regulatory function of SPARC in vascular biology10.1007/s00018-011-0781-8 ↗
55. Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor β: comparison of transcriptional and post‐transcriptional control with fibronectin and type I collagen10.1111/j.1432-1033.1991.tb15940.x ↗
56. Trans differentiation of chondrocytes to osteoblasts during endochondral ossification in the healing mandible10.1096/fasebj.30.1_supplement.1039.11 ↗
57. The art of building bone: emerging role of chondrocyte-to-osteoblast transdifferentiation in endochondral ossification10.1038/s41413-018-0021-z ↗
58. Overexpression of human IGF-I via direct rAAV-mediated gene transfer improves the early repair of articular cartilage defects in vivo10.1038/gt.2014.58 ↗
59. Bone development10.1016/j.bone.2015.04.035 ↗
60. Comparative analysis of in vitro angiogenic activities of endothelial cells of heterogeneous origin10.1006/mvre.2002.2406 ↗
61. Cloned endothelial cells from fetal bovine bone10.1073/pnas.86.3.916 ↗